Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
SH-group modification abolishes myosin Ca-ATPase; extends basic contractile protein insights while leaving cardiac clinical relevance open.
Myosin was treated with DHT (diazonium-1H-tetrazole) in the presence or absence of Mg-ATP. Results indicated that the SH-groups of myosin were modified by DHT. To prevent reaction of the SH-groups of myosin with DHT, the groups were blocked reversibly by DGM through their conversion to disulfide bonds. The Ca2+.ATPase [EC 3.6.1.3] activity of myosin disappeared on treatment with DGM (dithiodiglycolic acid dimethyl ester) for 50 hr and the amount of free SH-groups decreased to 2 moles per mole of myosin. The Ca2+ATPase activity was restored to the original level by reversing the blocking reaction with excess βME or DTT. DGM-treated myosin was treated with DHT, and then with β-ME or DTT. The Ca2+-ATPase activity decreased linearly with increase in the amount of monoazotyrosine in myosin, and complete inactivation occurred when approximately one mole of monoazo-tyrosine was formed per 4.0×105g of myosin. During treatment of DGM-treated myosin with DHT, the Ca2+-ATPase activity was protected to some extent by the presence of Mg-ATP. H-Meromyosin prepared by tryptic digestion of azo-myosin had the same monoazo-tyrosine content as the parent myosin. All the monoazo-tyrosine was present in the f-subunit. When a few moles of tyrosine residues per mole of myosin were modified with DHT, myosin became soluble even in water. One mole of tyrosine residue per mole of L-meromyosin fraction 1 reacted specifieally with DHT, and filament formation in L-meromyosin fraction 1 was inhibited by this modification with DHT.
No takes yet. Share an insight, caveat, or question.
Takamichi Shimada (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: